United States · 
Who invested in Cyrano Therapeutics?
Cyrano Therapeutics's investors include DeepWork Capital, Lumira Ventures, Florida Opportunity Fund and Remiges Ventures.
United States · Series B startup
Who invested in Cyrano Therapeutics
Funding summaryUpdated 26 Oct 2026
$9.0Mraised across 1 round since 2024, from 2 sources
- Latest round
- Series B, $9.0MJan 2024
- Investors
- 4
The rounds
- Jan 2024Series B$9.0M
Reported by Firms' own news pages and 1 other
Founders and team
From Cyrano Therapeutics's own website and the SEC filings it signed: 1 founder, 4 on the team.
Rick GeoffrionFounder, President and CEO
- Joe SmithHead of Business Development
- Krista GeoffrionVP of Clinical Affairs
- Michaela KennedyController
- Richard GeoffrionExecutive Officer, Directori
On the board, as filediRobert HenkinTakahide Koda
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cyrano Therapeutics
How much has Cyrano Therapeutics raised?
Cyrano Therapeutics has raised $9.0M across 1 round since 2024.
When did Cyrano Therapeutics last raise?
Cyrano Therapeutics's most recent round was a Series B of $9.0M in Jan 2024.
What was Cyrano Therapeutics's biggest round?
Its most recent round, $9.0M in Jan 2024, is also its largest on record.
Who backed Cyrano Therapeutics first?
Cyrano Therapeutics's first round on record, in Jan 2024, was backed by DeepWork Capital, Lumira Ventures and Florida Opportunity Fund and 1 others.
What stage is Cyrano Therapeutics at?
Cyrano Therapeutics's latest named round is a Series B, in Jan 2024.
Where is Cyrano Therapeutics based?
Cyrano Therapeutics is based in the United States.
Companies like Cyrano Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.